Your browser doesn't support javascript.
loading
Treatment of orbital lymphatic malformation with oral sirolimus: a case report.
Alba-Linero, Carmen; García-Lorente, María; Rachwani-Anil, Rahul; Luque-Aranda, Guillermo; Pérez-Cabeza, María-Isabel; Escudero, Julia.
Afiliação
  • Alba-Linero C; Ophthalmology Department, Hospital Regional of Malaga, Malaga, Spain.
  • García-Lorente M; School of Medicine, University of Malaga, Malaga, Spain.
  • Rachwani-Anil R; Ophthalmology Department, Hospital Regional of Malaga, Malaga, Spain.
  • Luque-Aranda G; Ophthalmology Department, Hospital Regional of Malaga, Malaga, Spain.
  • Pérez-Cabeza MI; Ophthalmology Department, Hospital Regional of Malaga, Malaga, Spain.
  • Escudero J; Ophthalmology Department, Hospital Regional of Malaga, Malaga, Spain.
Arq Bras Oftalmol ; 87(1): e20230072, 2022.
Article em En | MEDLINE | ID: mdl-35544942
It is estimated that lymphatic malformations in children account for 6% of all benign vascular malformations. New medical therapies have been developed for the management of lymphatic orbital disease. The purpose of this article was to describe a clinical case of orbital venolymphatic malformation in a 10-year-old boy, causing proptosis and palpebral edema. The lesion was initially treated with local sclerotherapy. However, the lesion relapsed, and was successfully treated with oral sirolimus. Prospective studies are warranted to determine the appropriate dose and extend the indications of sirolimus in these patients.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article